Seer Inc. Faces Activist Pressure Over Governance and Financial Performance
Event summary
- The Radoff-JEC Group, owning 7.5% of Seer Inc., issued an open letter to the board criticizing governance and financial performance.
- Seer's share price has declined over 96% since its IPO in December 2020.
- The company reported $150.2 million in cash used in operations and capital expenditures from 2022 to 2025, with only $2 million revenue growth.
- CEO Omid Farokhzad's total compensation was $24.9 million from 2021 to 2024.
The big picture
The Radoff-JEC Group's open letter highlights significant governance and financial performance concerns at Seer Inc., reflecting broader trends in activist investing targeting underperforming biotech companies. The criticism of executive compensation and operational inefficiencies underscores the growing scrutiny on corporate governance in the healthcare sector.
What we're watching
- Governance Dynamics
- Whether the board will implement significant governance changes or commence a sale process as urged by the Radoff-JEC Group.
- Financial Performance
- The pace at which Seer can achieve profitability, currently projected for 2031 under the existing strategic plan.
- Investor Confidence
- How investor confidence will be affected by the persistent discount of Seer's shares to its net cash balance and the ongoing governance issues.
Related topics